MannKind | Spese Operative



Operating Expenses Cambiamento Data
Adma Biologics USD 80.47M 268K 2024-12
Dynavax Technologies USD 81.01M 10.78M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Halozyme Therapeutics USD 123.28M 48K 2025-06
Insmed USD 361.29M 20.33M 2025-06
MacroGenics USD 35.94M 20.58M 2024-12
MannKind USD 65.86M 9.8M 2025-06
Merck USD 9.44B 217M 2025-06
Novo Nordisk DKK 39.3B 1.81B 2025-03
Pfizer USD 11.62B 1.58B 2025-06
Sanofi EUR 9.02B 702M 2025-06
Xencor USD 76.78M 865K 2025-06


MannKind Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.